Figure 2. A.1. Representative overlays of rhodamine-123 (Rho-123) fluorescence intensity histograms in unstimulated and PMA-stimulated (phorbol-12-myristate-13-acetate) monocytes from healthy donors. B.1. Representative overlays of rhodamine-123 (Rho-123) fluorescence intensity histograms in unstimulated and PMA-stimulated (phorbol-12-myristate-13-acetate) monocytes from patients with mild atopic bronchial asthma (ABA). C.1. Representative histograms of rhodamine-123 (Rho-123) fluorescence intensity in unstimulated and PMA-stimulated (phorbol-12-myristate-13-acetate) monocytes from patients with moderate atopic bronchial asthma (ABA). D.1. Representative overlays of rhodamine-123 (Rho-123) fluorescence intensity histograms in unstimulated and PMA-stimulated (phorbol-12-myristate-13-acetate) monocytes from patients with severe atopic bronchial asthma (ABA). Rho-123 fluorescence was measured in monocytes in channel FL1 (Fig. 2: A.1., B.1., C.1., D.1., left side —unstimulated with PMA), representing the fluorescence of unoxidized DHR-123. Stimulated PMA cells (right side) show significantly higher Rho-123 fluorescence due to oxidation of DHR-123. A.2. Results of Rho-123 fluorescence intensities in each group of monocytes.